Eye injections hailed by experts as 'big step' in fighting sight loss ... trends now
View
comments
Thousands of people at risk of blindness could be spared monthly injections thanks to a new drug that slows the progression of a common eye problem.
The medication, faricimab, could soon be offered to patients being treated for retinal vein occlusion (RVO), a leading cause of vision loss in the over-60s.
Current treatments for the condition have to be given via an injection into the eye once a month, but the new medication is so effective that trails suggest just three jabs a year are needed.
Experts say this could be a 'big step' for patients suffering from the degenerative disease.
Faricimab could soon be offered to patients being treated for retinal vein occlusion (RVO), a leading cause of
